DeviceTalks Podcast Network – Details, episodes & analysis

In this episode of the DeviceTalks Weekly podcast, HighRidge Medical CEO Rebecca Whitney and Executive Chairman Eric Major introduce us to the spine industry’s newest player. HighRidge combines the former spinal business of Zimmer Biomet (and later ZimVie) with seasoned executive spirit from K2M, Stryker and others. Can HighRidge compete? Will robotics and other tech be part of the story? Whitney has been on podcasts before. Listen here https://www.youtube.com/watch?v=6xtHK-FVeec and here https://youtu.be/0Ve_7NpIauQ?si=Wp-ytFHlq4ZWHeCC. Host Tom Salemi and DeviceTalks Editor Kayleen Brown chat with MedtechVISION co-chairs Kate Stephenson, PhD, and Shelia Shah about the upcoming conference organized by the MedtechWOMEN group. A few spaces are still available. Go to MedtechWOMEN.org to register. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of DeviceTalks AI, host Kayleen Brown sits down with Eigil Samset, PhD, General Manager for Cardiology Care at GE HealthCare. Dr. Samset takes us through his vast experience stretching over nearly three decades and discusses the transformative role of AI in advancing healthcare, particularly how GE HealthCare is leveraging AI to streamline and enhance cardiology care pathways. In the episode, Dr. Samset gives us the backstory of the 2023 Caption Health acquisition and provides insights into the inspiration behind Caption AI for use in Vscan, which democratizes cardiac assessments by making them accessible to less experienced users. The conversation touches on the regulatory challenges, the importance of multi-disciplinary collaboration, and GE HealthCare's strategic approach to integrating AI – aiming to improve patient outcomes and care pathways significantly. This conversation comes to you courtesy of our episode sponsor, DeviceTalks West. Listen to the episode for 25% OFF the registration rate: West.DeviceTalks.com. Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients. But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe now to the DeviceTalks Podcast Network.

The global release of Exactech's next-generation GPS Shoulder system marks an important milestone in shoulder arthroplasty. The launch, taking place in EMEA and APAC countries, follows the first surgery in the United Arab Emirates earlier this month. Fast Five Hosts Danielle Kirsh and Chris Newmarker share details about the orthopedic device and what doctors think of the system. With a new CE mark, Establishment Labs has completed a full transition of all currently marketed Motiva implants and tools, as well as the company’s quality management systems, to be in compliance with the new European Medical Device Regulation (MDR). Newmarker explains the devices included in the new indication and what surgeons and executives think about it. The FDA’s breakthrough designation for CardioRenal's Tenor at-home blood potassium measuring device signifies a significant advancement in monitoring and managing blood potassium levels in patients. This innovative device enables individuals to conveniently and accurately measure their potassium levels from the comfort of their own homes. Kirsh and Newmarker explain the benefits of at-home monitoring and how Tenor works. The clash between Masimo management and activist investor Politan has brought attention to the strategic direction and governance of the company. With differing perspectives on key decisions and company performance, this dispute highlights the challenges faced by organizations in managing shareholder expectations. Newmarker details the disagreement between the two parties and who on the board of directors is up for a vote. iRhythm’s receipt of an FDA warning letter regarding its Zio AT quality systems highlights the importance of robust quality control measures in the medical device industry. iRhythm’s response to the FDA warning letter and its actions to address the identified issues will be closely watched by regulators. Hear more about the warning letter from the Fast Five hosts.

The partnership between HeartBeam and Samsung is a significant development in the field of cardiac care, as it combines HeartBeam’s expertise in cardiac services with Samsung’s global reach and technological prowess. Fast Five hosts Danielle Kirsh and Chris Newmarker have all the details of the partnership. Concept Medical’s FDA IDE approval for the sirolimus-coated balloon MagicTouch PTA is a significant development in the treatment of superficial femoral artery disease. This approval allows for the investigation of the device’s safety and efficacy in treating this condition. Kirsh and Newmarker discuss the approval and the other indications the device has received in recent months. Think Surgical’s FDA clearance of its handheld robotic knee surgery device, the TMINI miniature robotic system, represents a major milestone in the field of orthopedic surgery. This innovative technology assists surgeons in performing total knee surgeries with enhanced precision and control. Newmarker explains how the technology works and how it compares to other surgical robots on the market. The transition of Medtronic’s Cardiovascular Diagnostics and Services President Julie Brewer to Baxter highlights the mobility and talent exchange within the medical device industry. Kirsh and Newmarker talk about the shuffle amidst a time of layoffs. Titan Medical’s decision to license out all of its intellectual property to Intuitive Surgical signifies a strategic shift in the company’s focus. In a push to further reduce operating costs in the business, Titan Medical also announced some executive changes, including the resignation of its CEO. Newmarker shares all the details of the licensing deal and who’s moving on in the executive suite.

In this episode, Cheryl R. Blanchard, Ph.D., CEO of Anika Therapeutics, explains how the company is morphing from a biomaterials into a joint preservation business. In an interview with Tom Salemi, editorial director of DeviceTalks, Blanchard points to collaboration she had with biomedical greats over her career, including a formative connection with Ray Elliott, the former CEO of Zimmer. Today, through sizable M&A and internal development, Anika is building a portfolio of ortho biomaterials and new joints that gives is more shots on net. Blanchard explains how Anika’s opportunity has grown its market opportunity from $1 billion to $8 billion. Chris Newmarker, executive editor of life sciences, brings this week’s Newmarker’s Newsmakers bringing news from Neuralink, Abbott, Cala Health, Cue Health, Medtronic, and Zoll Medical. Senior Editor Danielle Kirsh also visits to introduce DeviceTalks Weekly listeners to the new Fast Five Podcast, a daily podcast highlighting the biggest news in medtech. You can subscribe to the MassDevice Fast Five on any major podcast application. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to receive future episodes of this podcast as well as Boston Scientific Talks, IntuitiveTalks, and StrykerTalks.

This episode of DeviceTalks Weekly brings you DeviceTalks Boston’s opening keynote conversation with Tom Polen, CEO, President and Chairman of Becton Dickinson. In the conversation, Polen recounts his tragic first encounter with the medical device industry, his path into medtech and the CEO’s chair, and the work BD put into helping the world survive the COVID-19 pandemic while also repositioning the company with key M&A and divestitures. The episode was sponsored by Clari. Go to Clari.com to learn about its unique revenue management platform. Chris Newmarker also delivers his Newmarker’s Newsmakers featuring news from Siemens Healthineers, Abbott, Intuitive, Cook Medical, Shockwave Medical, Medtronic and Johnson & Johnson. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast application.

In this compelling episode of Boston Scientific Talks, Kathryn Unger, VP of ESG, and Brad Sorenson, EVP of Global Operations, delve into Boston Scientific's transformative Environmental, Social, and Governance (ESG) initiatives, exploring how these principles are influencing supplier relationships, impacting product design, and exceeding customer expectations. Additionally, they discuss strategies to align business operations with ESG objectives to foster employee engagement, improve patient outcomes, and better support communities. Tune in to this episode for a comprehensive understanding of Boston Scientific's commitment to balancing quality, environmental sustainability, and social responsibility in the medical device industry. Thank you to Canon Virginia for sponsoring this episode. To learn more about how Canon Virginia works with medical device companies, visit www.cvi.canon.com/ Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In our closing session of DeviceTalks Boston, Chris Newmarker, executive editor of life sciences, and Tom Salemi, Editorial Director of DeviceTalks, sit down with two leaders in the field to break down the event and highlight some of the changes coming Medtech’s ways. Joe Mullings, CEO of the Mullings Group, and former J&J Medtech leader Peter Stebbins, now executive chairman of Nurami Medical, cover a broad range of topics on how will Big Pharma, AI, data, private equity and other external forces will impact the medical device industry. Are we going to see more roll ups from PE? Will a new threat emerge to thwart Medtech’s connected care plan. Also, what were the takeaways from the discussions of the conference. Give a listen. Thanks to everyone who made DeviceTalks Boston so special! Thanks for listening to the DeviceTalks Weekly podcast. Subscribe on any podcast application.

Last call for DeviceTalks Boston! In this episode we'll preview our upcoming conference by talking with Paul Grand, CEO of Medtech Innovator, Rebecca Whitney, SVP at ZimView, Holly Scott and Joe Mullings at the Mullings Group. We'll have Fastball Pitches from two Medtech Innovator companies that will be presenting on May 10-11. Register at DeviceTalks.com. Use the code DTWeekly25 to save 25% Chris Newmarker delivers his #newmarkernewsmakers featuring 3M, Zimmer Biomet, Stryker, Medtronic and Casana, maker of a now FDA-approved smart toilet seat. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Player on any major podcast application.